Instrument Inactif

Communiqués Blue Water Ventures International, Inc. Other OTC

Actions

BWVI

US09609E1055

Recherche biotechnologique et médicale

Communiqués

01/10/25	Blue Water pitches $10bn offer for Citgo in Delaware court	AQ
16/09/25	Delaware court opens Venezuela’s Citgo sale battle as creditors vie for control	AQ
09/09/25	Blue Water bids $10bn for Venezuela’s Citgo, offers bondholders cash and equity	AQ
31/07/25	Blue Water Suriname secures contract to support Noble Corporation drilling operations	AQ
13/04/23	Psycheceutical Bioscience, Inc. Named a 2023 Top 10 Biotech Startup by Life Sciences Review	PR
29/03/23	Psycheceutical Hosts MAPS Founder and Psychedelic Industry Leader Rick Doblin at Its Drug Development Lab	GL
21/03/23	Psycheceutical Bioscience, Inc. Announces Observational Research Results for NeuroDirect™ Ketamine Topical Cream in Treating PTSD	GL
21/03/23	Psycheceutical Bioscience, Inc. Announces Observational Research Results for NeuroDirect™ Ketamine Topical Cream in Treating PTSD	AQ
15/02/23	Psycheceutical to Conduct the First Ever Phase I and II Clinical Trials of a Novel Ketamine Topical Cream to Treat PTSD	GL
15/02/23	Psycheceutical to Conduct the First Ever Phase I and II Clinical Trials of a Novel Ketamine Topical Cream to Treat PTSD	AQ
02/02/23	Psycheceutical Announces Completion of Pre-IND Meeting with FDA for Topical Ketamine Drug to Treat PTSD	GL
02/02/23	Psycheceutical Announces Completion of Pre-IND Meeting with FDA for Topical Ketamine Drug to Treat PTSD	AQ
26/01/23	Psycheceutical Bioscience Provisional Patent Application for Novel Ketamine Topical for the Treatment of PTSD	GL
26/01/23	Psycheceutical Bioscience Provisional Patent Application for Novel Ketamine Topical for the Treatment of PTSD	AQ
10/01/23	Psycheceutical Announces Julian Bailes, M.D. as Board Member and Chief Medical Officer	GL
10/01/23	Psycheceutical Announces Julian Bailes, M.D. as Board Member and Chief Medical Officer	AQ
29/11/22	Dr. Aric Logsdon Joins Psycheceutical Bioscience, Inc. as Company’s Scientific Director	GL
29/11/22	Dr. Aric Logsdon Joins Psycheceutical Bioscience, Inc. as Company’s Scientific Director	AQ
18/10/22	Psycheceutical Bioscience, Inc. Announces Medical Advisory Board	GL
18/10/22	Psycheceutical Bioscience, Inc. Announces Medical Advisory Board	AQ
05/10/22	Kevin Harrington, Original Shark from Shark Tank and Futurist Zappy Zapolin to Open Wonderland 2022	NE
04/10/22	Psycheceutical Bioscience, Inc.'s Zappy Zapolin Added to The Benzinga Psychedelics Advisory Council	GL
04/10/22	Psycheceutical Bioscience, Inc.'s Zappy Zapolin Added to The Benzinga Psychedelics Advisory Council	AQ
13/09/22	Psycheceutical Bioscience, Inc.'s CEO to Present at the Life Sciences Investor Forum on September 15	GL
13/09/22	Psycheceutical Bioscience, Inc.'s CEO to Present at the Life Sciences Investor Forum on September 15	AQ